Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Nickolas Zaller to Drug Overdose

This is a "connection" page, showing publications Nickolas Zaller has written about Drug Overdose.

 
Connection Strength
 
 
 
1.511
 
  1. Davis CS, Green TC, Zaller ND. Addressing the overdose epidemic requires timely access to data to guide interventions. Drug Alcohol Rev. 2016 07; 35(4):383-6.
    View in: PubMed
    Score: 0.445
  2. Ostrach B, Buer LM, Armbruster S, Brown H, Yochym G, Zaller N. COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains. J Rural Health. 2021 01; 37(1):252-255.
    View in: PubMed
    Score: 0.156
  3. Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018 11; 86:104-110.
    View in: PubMed
    Score: 0.132
  4. Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, Martino S, Bouvier B, Rich J. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017 03 13; 13(1):25-31.
    View in: PubMed
    Score: 0.124
  5. Saucier CD, Zaller N, Macmadu A, Green TC. An Initial evaluation of law enforcement overdose training in Rhode Island. Drug Alcohol Depend. 2016 May 01; 162:211-8.
    View in: PubMed
    Score: 0.116
  6. Yokell MA, Delgado MK, Zaller ND, Wang NE, McGowan SK, Green TC. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Intern Med. 2014 Dec; 174(12):2034-7.
    View in: PubMed
    Score: 0.106
  7. Green TC, Zaller N, Palacios WR, Bowman SE, Ray M, Heimer R, Case P. Law enforcement attitudes toward overdose prevention and response. Drug Alcohol Depend. 2013 Dec 01; 133(2):677-84.
    View in: PubMed
    Score: 0.097
  8. Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013 Jun; 48(8):590-9.
    View in: PubMed
    Score: 0.095
  9. Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse. 2013 May; 48(7):558-67.
    View in: PubMed
    Score: 0.095
  10. Green TC, Zaller N, Rich J, Bowman S, Friedmann P. Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose". Pain Med. 2011 Jun; 12(6):982-5.
    View in: PubMed
    Score: 0.083
  11. Yokell MA, Zaller ND, Green TC, McKenzie M, Rich JD. Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose. J Opioid Manag. 2012 Jan-Feb; 8(1):63-6.
    View in: PubMed
    Score: 0.022
  12. Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev. 2011 Mar; 4(1):28-41.
    View in: PubMed
    Score: 0.020
  13. Bazazi AR, Zaller ND, Fu JJ, Rich JD. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010 Nov; 21(4):1108-13.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.